English
Meet us at the 3rd scientific day of the French Faecal Transplantation Group.
GenoScreen is a sponsor of the 3rd scientific day of the French Faecal Transplantation Group (GFTF) on June 28th at the VILMER amphitheatre of the Robert Debré Hospital, Paris.
Meet-us at MedFIT 2019 !
On June 25 and 26, GenoScreen will participate in the 3rd edition of MedFIT, which will be held this year in Lille Grand Palais.
Review : discover a new review in the ERS Monograph !
Discover the review “From culturomics to metagenomics: the mycobiome in chronic respiratory diseases” by Louise-Eva Vandenborght, PHD student at GenoScreen, in the ERS Monograph n°83 on “The Lung Microbiome” !
Meet us at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
GenoScreen will be present at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) on April 13 in Amsterdam.
Meet us at the POLEPHARMA Microbiomics Days
GenoScreen will participate in the 1st edition of the POLEPHARMA Microbiomics Days which will be organized on April 9 & 10 at the HEALTH UFR of the University of Rouen.
Metabiote® protocol is now GCLP compliant
Metabiote®, the reference protocol in targeted metagenomics developed by GenoScreen, is now GCLP compliant.
A major advance in the fight against multidrug-resistant tuberculosis
Deeplex®-MycTB, was used in a study published in The Lancet Infectious Diseases highlighting the spread of tuberculosis strains resistant to first-line antibiotics, not detected by current diagnostic tests.
Subcategories
GenoScreen
Collaborative research - At the heart of international innovation in genomics
GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.
Our projects are designed to:
- Improve the diagnosis and management of acute/chronic diseases on humans and animals,
- Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.
The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.